Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41

被引:136
作者
Liu, SW
Lu, H
Zhao, Q
He, YX
Niu, JK
Debnath, AK
Wu, SG
Jiang, SB
机构
[1] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA
[2] So Med Univ, Inst Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China
[3] So Med Univ, Anti Viral Res Ctr, Guangzhou 510515, Guangdong, Peoples R China
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2005年 / 1723卷 / 1-3期
关键词
tea polyphenol; HIV entry inhibitor; HIV-1; gp41; six-helix bundle; theaflavin;
D O I
10.1016/j.bbagen.2005.02.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Theaflavin derivatives and catechin derivatives are the major polyphenols in black tea and green tea, respectively. Several tea polyphenols, especially those with galloyl moiety, can inhibit HIV-1 replication with multiple mechanisms of action. Here we showed that the theaflavin derivatives had more potent anti-HfV-1 activity than catechin derivatives. These tea polyphenols could inhibit HIV-1 entry into target cells by blocking HIV-1 envelope glycoprotein-mediated membrane fusion. The fusion inhibitory activity of the tea polyphenols was correlated with their ability to block the formation of the gp41 six-helix bundle, a fusion-active core conformation. Computer-aided molecular docking analyses indicate that these tea polyphenols, theaflavin-3,3 '-digallate (TF3) as an example, may bind to the highly conserved hydrophobic pocket on the surface of the central trimeric coiled coil formed by the N-terminal heptad repeats of gp41. These results indicate that tea, especially black tea, may be used as a source of anti-HIV agents and theaflavin derivatives may be applied as lead compounds for developing HIV-1 entry inhibitors targeting gp41. circle dot 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:270 / 281
页数:12
相关论文
共 46 条
[1]   A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [J].
Baba, M ;
Nishimura, O ;
Kanzaki, N ;
Okamoto, M ;
Sawada, H ;
Iizawa, Y ;
Shiraishi, M ;
Aramaki, Y ;
Okonogi, K ;
Ogawa, Y ;
Meguro, K ;
Fujino, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5698-5703
[2]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[3]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[4]   Antiviral drugs in current clinical use [J].
De Clercq, E .
JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (02) :115-133
[5]   A review of latest research findings on the health promotion properties of tea [J].
Dufresne, CJ ;
Farnworth, ER .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2001, 12 (07) :404-421
[6]   Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent [J].
Fassina, G ;
Buffa, A ;
Benelli, R ;
Varnier, OE ;
Noonan, DM ;
Albini, A .
AIDS, 2002, 16 (06) :939-941
[7]   HIV and AIDS: 20 years of science [J].
Fauci, AS .
NATURE MEDICINE, 2003, 9 (07) :839-843
[8]   ENVELOPE GLYCOPROTEINS OF HIV-1, HIV-2, AND SIV PURIFIED WITH GALANTHUS-NIVALIS AGGLUTININ INDUCE STRONG IMMUNE-RESPONSES [J].
GILLJAM, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (05) :431-438
[9]   Biochemical characterization of casein kinase II as a protein kinase responsible for stimulation of HIV-1 protease in vitro [J].
Haneda, E ;
Furuya, T ;
Asai, S ;
Morikawa, Y ;
Ohtsuki, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (02) :434-439
[10]   Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120-CD4 complex in transgenic mice that produce human immunoglobulins [J].
He, YX ;
D'Agostino, P ;
Pinter, A .
VACCINE, 2003, 21 (27-30) :4421-4429